Last reviewed · How we verify
CP CB-MNC injection
CP CB-MNC injection is a cell-based therapy that utilizes mesenchymal stem cells to modulate the immune system.
CP CB-MNC injection is a cell-based therapy that utilizes mesenchymal stem cells to modulate the immune system. Used for Treatment of graft-versus-host disease.
At a glance
| Generic name | CP CB-MNC injection |
|---|---|
| Sponsor | State-Financed Health Facility "Samara Regional Medical Center Dinasty" |
| Drug class | Cell-based therapy |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 2 |
Mechanism of action
The exact mechanism of action is not fully understood, but it is believed to involve the suppression of inflammation and promotion of tissue repair through the release of anti-inflammatory cytokines and growth factors.
Approved indications
- Treatment of graft-versus-host disease
Common side effects
- Infusion-related reactions
- Infection
- Bleeding
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: